IL‐33 concentrations in AIS patients with good functional outcome were significantly higher than those with unfavorable outcome (62.45 ± 20.50 ng/ml vs. 51.58 ± 19.16 ng/ml, p < .001). Here, IL33 is linked to androgen insensitivity syndrome.